Metabolomics of Empagliflozin after acute MI

Disciplines

Other Human Medicine, Health Sciences (10%); Clinical Medicine (60%); Medical Biotechnology (30%)

Keywords

SGLT2-inhibition, Myocardial Infarction, Metabolomics, Empagliflozin